For cervical cancer therapy, targeting HPV driver genes with CRISPR/Cas9 offers a promising approach.114,115 Research studies have shown, gene editing tools can restore proteins like p53 and pRb by correcting E6/E7 oncogenes. This evidence concerns the gene TP53 and cervical carcinoma.